9 Meters Biopharma Announces Allowance of Patent for NM-102 in Combination with Immune Checkpoint Inhibitors. ACCESS Newswire . Mon, Jan 24, 2022, 8:00 AM 5 min read. In This Article: ...

Patent protection of ONCOS-102 in combination with chemotherapy in malignant pleural mesothelioma in Europe OSLO, Norway, Sept. 24, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical.

Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan. Acasti Pharma, Inc. Tue, Mar 22, 2022, 7:30 AM 3 min read. Acasti Pharma, Inc.

OSLO, Norway, Sept. 24, 2021 /PRNewswire/ -- <b> Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to ...

OSLO, Norway, Sept. 24, 2021 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announce ...

OSLO, Norway, Oct. 12, 2020 /PRNewswire/ -- Targovax ASA ("Targovax" or "the Company") (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat ...